Quilt Health Secures $6M to Transform Clinical Trials for Complex Diseases
June 18, 2025, 3:33 am
In the ever-evolving landscape of healthcare, Quilt Health emerges as a beacon of hope. This Boston-based digital health company has just secured $6 million in seed funding, bringing its total funding to $8 million. The round was led by MaC Venture Capital and Underscore Ventures, with additional backing from Meridian Street Capital, BoxGroup, Watershed VC, and Coalition Operators.
Quilt Health is on a mission to bridge the chasm between treatment access and clinical trials for complex diseases. The founders, Andy Ellner and Jazmine Coleman, have set their sights on modernizing the clinical trial process, which has long been mired in inefficiency.
The clinical trial landscape is akin to a labyrinth. Despite decades of innovation, many trials fail to meet enrollment thresholds. This is especially true for rare diseases, where patient pools are small and hard to reach. Over 70% of trials fall short, leaving many patients without access to potentially life-saving treatments. Quilt Health aims to change that narrative.
The company’s technology is a game-changer. It integrates multiple data sources and employs artificial intelligence to sift through unstructured data. This approach reveals key patient characteristics and outcomes, streamlining the recruitment process. It’s like turning on a light in a dark room, illuminating the path for patients, researchers, and pharmaceutical sponsors alike.
For pharmaceutical sponsors, Quilt Health’s platform accelerates trial execution. It reduces operational costs and enhances patient enrollment diversity. This is crucial. Diverse trials yield better data, leading to more effective treatments for a broader range of patients.
Research sites and clinicians also stand to benefit. They gain access to streamlined workflows and enhanced data collection tools. This allows them to focus on what truly matters: delivering high-quality care and conducting meaningful research. The platform acts as a supportive partner, lifting some of the burdens off their shoulders.
Patients are at the heart of Quilt Health’s mission. The platform’s engagement tools keep patients connected with their clinicians between visits. This continuous connection improves care and makes cutting-edge treatments more accessible. It’s about creating a bridge between patients and the innovations that can change their lives.
A significant milestone for Quilt Health is its partnership with the National Alliance of Sickle Cell Centers (NASCC). This collaboration provides Quilt Health with a national network of over 115 sickle cell centers. Together, they aim to create a patient-centered ecosystem that accelerates the path to market for life-saving treatments.
The funding will not only fuel product development and research but also expand the Quilt Health team. The company plans to partner with high-quality health systems in regions that have historically been overlooked by major life sciences investments. This is a strategic move, ensuring that the benefits of innovation reach those who need it most.
Quilt Health is not just another tech startup. It’s a lifeline for patients grappling with complex diseases. The founders understand the urgency. They know that time is of the essence when it comes to treatment access.
As the healthcare landscape continues to shift, Quilt Health stands ready to lead the charge. The infusion of capital will allow them to innovate faster and reach more patients. It’s a race against time, and Quilt Health is determined to win.
The company’s vision is clear: to modernize clinical trial access and ensure that no patient is left behind. They are committed to transforming the way clinical trials are conducted, making them more inclusive and efficient.
In a world where healthcare can often feel like a maze, Quilt Health is the compass guiding patients toward hope and healing. The journey is just beginning, but the potential is immense. With each step forward, they are not just changing the clinical trial landscape; they are changing lives.
As we look to the future, Quilt Health’s innovative approach could redefine how we think about clinical trials. It’s about more than just data and technology; it’s about people. It’s about connecting patients with the treatments they need.
In the end, Quilt Health is weaving a new tapestry in the world of healthcare. One that is inclusive, efficient, and patient-centered. The $6 million in funding is not just a financial boost; it’s a promise. A promise to transform clinical trials and improve access to life-saving treatments for millions.
The road ahead may be challenging, but with determination and innovation, Quilt Health is poised to make a significant impact. The future of clinical trials is bright, and Quilt Health is leading the way.
Quilt Health is on a mission to bridge the chasm between treatment access and clinical trials for complex diseases. The founders, Andy Ellner and Jazmine Coleman, have set their sights on modernizing the clinical trial process, which has long been mired in inefficiency.
The clinical trial landscape is akin to a labyrinth. Despite decades of innovation, many trials fail to meet enrollment thresholds. This is especially true for rare diseases, where patient pools are small and hard to reach. Over 70% of trials fall short, leaving many patients without access to potentially life-saving treatments. Quilt Health aims to change that narrative.
The company’s technology is a game-changer. It integrates multiple data sources and employs artificial intelligence to sift through unstructured data. This approach reveals key patient characteristics and outcomes, streamlining the recruitment process. It’s like turning on a light in a dark room, illuminating the path for patients, researchers, and pharmaceutical sponsors alike.
For pharmaceutical sponsors, Quilt Health’s platform accelerates trial execution. It reduces operational costs and enhances patient enrollment diversity. This is crucial. Diverse trials yield better data, leading to more effective treatments for a broader range of patients.
Research sites and clinicians also stand to benefit. They gain access to streamlined workflows and enhanced data collection tools. This allows them to focus on what truly matters: delivering high-quality care and conducting meaningful research. The platform acts as a supportive partner, lifting some of the burdens off their shoulders.
Patients are at the heart of Quilt Health’s mission. The platform’s engagement tools keep patients connected with their clinicians between visits. This continuous connection improves care and makes cutting-edge treatments more accessible. It’s about creating a bridge between patients and the innovations that can change their lives.
A significant milestone for Quilt Health is its partnership with the National Alliance of Sickle Cell Centers (NASCC). This collaboration provides Quilt Health with a national network of over 115 sickle cell centers. Together, they aim to create a patient-centered ecosystem that accelerates the path to market for life-saving treatments.
The funding will not only fuel product development and research but also expand the Quilt Health team. The company plans to partner with high-quality health systems in regions that have historically been overlooked by major life sciences investments. This is a strategic move, ensuring that the benefits of innovation reach those who need it most.
Quilt Health is not just another tech startup. It’s a lifeline for patients grappling with complex diseases. The founders understand the urgency. They know that time is of the essence when it comes to treatment access.
As the healthcare landscape continues to shift, Quilt Health stands ready to lead the charge. The infusion of capital will allow them to innovate faster and reach more patients. It’s a race against time, and Quilt Health is determined to win.
The company’s vision is clear: to modernize clinical trial access and ensure that no patient is left behind. They are committed to transforming the way clinical trials are conducted, making them more inclusive and efficient.
In a world where healthcare can often feel like a maze, Quilt Health is the compass guiding patients toward hope and healing. The journey is just beginning, but the potential is immense. With each step forward, they are not just changing the clinical trial landscape; they are changing lives.
As we look to the future, Quilt Health’s innovative approach could redefine how we think about clinical trials. It’s about more than just data and technology; it’s about people. It’s about connecting patients with the treatments they need.
In the end, Quilt Health is weaving a new tapestry in the world of healthcare. One that is inclusive, efficient, and patient-centered. The $6 million in funding is not just a financial boost; it’s a promise. A promise to transform clinical trials and improve access to life-saving treatments for millions.
The road ahead may be challenging, but with determination and innovation, Quilt Health is poised to make a significant impact. The future of clinical trials is bright, and Quilt Health is leading the way.